Market Cap (In KRW)
1089.32 Billion
Revenue (In KRW)
367.37 Billion
Net Income (In KRW)
669.01 Million
Avg. Volume
1.42 Million
- Currency
- KRW
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 19500.0-35950.0
- PE
- -
- EPS
- -
- Beta Value
- -1.139
- ISIN
- KR7096530001
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Specialties
- CEO
- Dr. Jong-Yoon Chun
- Employee Count
- -
- Website
- https://www.seegene.com
- Ipo Date
- 2010-09-10
- Details
- Seegene, Inc. manufactures and sells molecular diagnostics products worldwide. It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection products; drug resistance products; Magicplex sepsis real-time test for the detection and identification of sepsis causing pathogens; and meningitis detection products. The company also provides other products for the detection of six SNPs in factor II, factor V, and MTHFR genes; BRAF mutation characteristic for papillary thyroid carcinoma from samples of thyroid tissue, fine needle aspiration biopsy, H&E slides, and paraffin-embedded tissues; Apolipoprotein E genotypes; and BCR/ABL fusion gene from blood and whole bone marrow. In addition, it offers PCR machines; vial cap management systems; nucleic acid extraction systems; automated liquid handling workstations from nucleic acid extraction to PCR setup; and real-time PCR detection systems. Seegene, Inc. was founded in 2000 and is headquartered in Seoul, South Korea.
More Stocks
-
WIIK
-
PWONPT Pakuwon Jati Tbk
PWON
-
INBK
-
THX
-
3OY1
-
HKMPF
-
SLXXFFintech Select Ltd.
SLXXF
-
0991